題目：7/8 (Friday)的intern seminar 王鈺維的部份
Which of the following statement was true?
A. HLA-B*1502 Screening can reduce carbamazepine-induced toxic effects.
B. As first line therapy for advanced non-small cell cancer, Gefitinib can
prolong life of both EGFR mutation positive and negative patient.
C. Thiopurine methyltransferase genotyping can replace continued monitoring of
CBC and liver function tests.
D. Hercepin shows totally no benefit to HER2-negative patient.
Answer : A
--
※ 發信站: 批踢踢實業坊(ptt.cc)
◆ From: 140.112.212.178